Home › Funds › Beutel, Goodman & Co Ltd. › COR

Beutel, Goodman & Co Ltd. position in COR

CENCORA INC · Health Care

Beutel, Goodman & Co Ltd. reported holding 658,222 shares of COR (CENCORA INC) in its Q3 2026 13F filing — a position valued at US$197.6M, representing 1.56% of its reported portfolio and ranking #30 among its reported holdings. Beutel, Goodman & Co Ltd. has disclosed COR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)658.22K sh
Reported value held$197.63M
Portfolio Weight1.56%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Beutel, Goodman & Co Ltd.'s COR position evolved

Beutel, Goodman & Co Ltd. first disclosed a stake in COR in Q3 2023 at 668,224 shares (US$120.3M). The position peaked in Q3 2026 at 658,222 shares, worth US$197.6M. Across 13 filings, Beutel, Goodman & Co Ltd. increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 658,222 shares valued at US$197.6M — an increase of 148,544 shares quarter over quarter.. Notable position changes include a 35% trim in Q2 2025 (shares rose 4% over the following quarter), a 37% trim in Q4 2025 (shares fell 7% over the following quarter), a 168% increase in Q2 2026 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 668.22K $120.26M New
Q4 2023 665.68K $136.72M Hold
Q1 2024 676.54K $164.39M Add
Q2 2024 713.46K $160.74M Add
Q3 2024 470.27K $105.85M Reduce
Q4 2024 506.31K $113.76M Add
Q1 2025 510.78K $142.04M Add
Q2 2025 332.95K $99.83M Reduce
Q3 2025 317.22K $99.14M Reduce
Q4 2025 199.72K $67.45M Reduce
Q1 2026 190.41K $59.82M Reduce
Q2 2026 509.68K $144.23M Add
Q3 2026 658.22K $197.63M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About COR and 13F data

COR (CENCORA INC) is a Health Care company. 33 other funds we track also report a position in COR — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$2.10B), Boston Partners (US$1.58B), Mawer Investment Management Ltd. (US$413.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding COR

All COR fund holders →

FAQ

How long has Beutel, Goodman & Co Ltd. held COR?

Beutel, Goodman & Co Ltd. has disclosed COR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Beutel, Goodman & Co Ltd.'s current position in COR?

As of Q3 2026, Beutel, Goodman & Co Ltd. holds 658.22K shares of COR (CENCORA INC), valued at $197.63M, representing 1.56% of its reported portfolio and ranking #30.

Has Beutel, Goodman & Co Ltd. been buying or selling COR?

In the latest 13F filing (Q3 2026), Beutel, Goodman & Co Ltd. increased its position in COR. The position peaked in Q3 2026 at 658.22K shares.

Which other funds hold COR?

Other major institutional holders of COR include T. Rowe Price Investment Management, Inc., Boston Partners, Mawer Investment Management Ltd., among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.